Transgenic plants as bioreactors
نویسندگان
چکیده
Recent advances in molecular and cellular biology have led to the development of technology to engineer plants that are capable of producing a wide variety of products. These include products for pharmaceutical applications, like vaccine antigens, antibodies, antibody-derived fragments and other therapeutic proteins. It is possible to alter endogenous metabolic pathways to obtain new products, like plastics, or to confer novel traits, such as improved nutritional value.
منابع مشابه
Expression Systems and Species Used for Transgenic Animal Bioreactors
Transgenic animal bioreactors can produce therapeutic proteins with high value for pharmaceutical use. In this paper, we compared different systems capable of producing therapeutic proteins (bacteria, mammalian cells, transgenic plants, and transgenic animals) and found that transgenic animals were potentially ideal bioreactors for the synthesis of pharmaceutical protein complexes. Compared wit...
متن کاملVaccine antigen production in transgenic plants: strategies, gene constructs and perspectives.
Stable integration of a gene into the plant nuclear or chloroplast genome can transform higher plants (e.g. tobacco, potato, tomato, banana) into bioreactors for the production of subunit vaccines for oral or parental administration. This can also be achieved by using recombinant plant viruses as transient expression vectors in infected plants. The use of plant-derived vaccines may overcome som...
متن کاملDevelopment of plant-based mucosal vaccines against widespread infectious diseases.
Mucosal vaccination is a perspective for the control of infectious diseases, since it is capable of inducing humoral and cell-mediated responses. In addition, the delivery of vaccines to mucosal surfaces makes immunization practice safe and acceptable, and eliminates needle-associated risks. Transgenic plants can be used as bioreactors for the production of mucosally delivered protective antige...
متن کاملPlant Antibodies for lmmunotherapy
The use of transgenic plants for the expression of therapeutic recombinant proteins is gradually gaining acceptance in the scientific community (Moffat, 1995). There are many attractions to this technology, including the possibility of manufacture on an agricultural scale for bulk production and to reduce costs, as well as the range of plant hosts available and the stability of transgenic lines...
متن کاملPlants as bioreactors for the production of vaccine antigens.
Plants have been identified as promising expression systems for commercial production of vaccine antigens. In phase I clinical trials several plant-derived vaccine antigens have been found to be safe and induce sufficiently high immune response. Thus, transgenic plants, including edible plant parts are suggested as excellent alternatives for the production of vaccines and economic scale-up thro...
متن کامل